Cyclobenzaprine Prescription for Acute Muscle Spasm
For acute muscle spasm, prescribe cyclobenzaprine 5 mg three times daily for 7-14 days maximum, as this dose provides equivalent efficacy to 10 mg three times daily with significantly less sedation. 1, 2
Standard Dosing Regimen
- Start with 5 mg orally three times daily for most patients with acute painful musculoskeletal conditions 1, 2
- The 5 mg dose demonstrates comparable efficacy to 10 mg three times daily on all primary outcome measures (patient-rated clinical global impression of change, medication helpfulness, and relief from starting backache) 2
- Onset of relief occurs within 3-4 doses of the 5 mg regimen 2
- Maximum treatment duration is 2-3 weeks, as cyclobenzaprine is indicated only for acute conditions and lacks evidence for longer use 1
Dose Escalation (If Needed)
- If 5 mg three times daily provides inadequate relief after 3-4 days, increase to 10 mg three times daily 1
- However, the 10 mg dose increases sedation risk without substantially improving efficacy 2
- Do not prescribe 2.5 mg three times daily, as this dose is not significantly more effective than placebo 2
Critical Prescribing Caveats
Absolute Contraindications
- Never prescribe with MAO inhibitors due to serotonin syndrome risk 3, 4
- Not indicated for chronic musculoskeletal pain or spasticity from cerebral/spinal cord disease 3, 1
Special Populations Requiring Dose Reduction
- Elderly patients (≥65 years): Use less frequent dosing due to altered pharmacokinetics and anticholinergic effects; cyclobenzaprine appears on the Beers Criteria as potentially inappropriate 3, 1
- Hepatic impairment: Start at lowest effective dose with reduced frequency 3, 1
Discontinuation Protocol
- If used for >2-3 weeks, taper over 2-3 weeks to prevent withdrawal symptoms (malaise, nausea, headache) 3, 5, 4
- Abrupt discontinuation after prolonged use can cause significant withdrawal 5, 4
Monotherapy vs. Combination Therapy
- Cyclobenzaprine 5 mg three times daily as monotherapy is as effective as combination with ibuprofen (400 mg or 800 mg three times daily) 6
- Adding NSAIDs provides no additional benefit over cyclobenzaprine alone for acute muscle spasm 6
- 88% of patients report at least mild improvement after 3 days, and 93% after 7 days with monotherapy 6
Monitoring Requirements
- Assess anticholinergic side effects: drowsiness, dry mouth, urinary retention, constipation 5
- Monitor for drug interactions, particularly with serotonergic agents (SSRIs, SNRIs) which increase serotonin syndrome risk 4
- Evaluate efficacy at day 3-4: if no improvement, consider alternative therapy rather than prolonging treatment 2, 6
Common Pitfalls to Avoid
- Do not prescribe for chronic pain: all efficacy trials were ≤2 weeks duration, and insufficient evidence exists for chronic use 4
- Do not use in older adults without careful consideration: increased fall risk, sedation, and anticholinergic burden 3, 4
- Hold on day of surgery: potential interactions with sedatives and anesthetic agents 5, 4
- Efficacy is independent of sedation: meaningful treatment effects occur even in patients who do not report somnolence 2